Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 54

Related Articles by Review for PubMed (Select 23625194)

1.

Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility.

Panidis D, Tziomalos K, Papadakis E, Vosnakis C, Chatzis P, Katsikis I.

Endocrine. 2013 Dec;44(3):583-90. doi: 10.1007/s12020-013-9971-5. Epub 2013 Apr 27. Review.

PMID:
23625194
2.

Dietary therapy in polycystic ovary syndrome.

Moran LJ, Brinkworth GD, Norman RJ.

Semin Reprod Med. 2008 Jan;26(1):85-92. doi: 10.1055/s-2007-992928. Review.

PMID:
18181086
3.

Lifestyle changes in women with polycystic ovary syndrome.

Moran LJ, Hutchison SK, Norman RJ, Teede HJ.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD007506. doi: 10.1002/14651858.CD007506.pub3. Review.

PMID:
21735412
4.

The role of obesity in the development of polycystic ovary syndrome.

Motta AB.

Curr Pharm Des. 2012;18(17):2482-91. Review.

PMID:
22376149
5.

The role of lifestyle modification in polycystic ovary syndrome.

Norman RJ, Davies MJ, Lord J, Moran LJ.

Trends Endocrinol Metab. 2002 Aug;13(6):251-7. Review.

PMID:
12128286
6.

Lifestyle changes in women with polycystic ovary syndrome.

Moran LJ, Hutchison SK, Norman RJ, Teede HJ.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD007506. doi: 10.1002/14651858.CD007506.pub2. Review. Update in: Cochrane Database Syst Rev. 2011;(7):CD007506.

PMID:
21328294
7.

Cardiovascular risk in women with polycystic ovary syndrome.

Giallauria F, Orio F, Palomba S, Lombardi G, Colao A, Vigorito C.

J Cardiovasc Med (Hagerstown). 2008 Oct;9(10):987-92. doi: 10.2459/JCM.0b013e32830b58d4. Review.

PMID:
18799960
8.
9.

Role of lifestyle modification in the management of polycystic ovary syndrome.

Hoeger KM.

Best Pract Res Clin Endocrinol Metab. 2006 Jun;20(2):293-310. Review.

PMID:
16772159
10.

Longterm management of Polycystic Ovarian Syndrome (PCOS).

Bates GW, Legro RS.

Mol Cell Endocrinol. 2013 Jul 5;373(1-2):91-7. doi: 10.1016/j.mce.2012.10.029. Epub 2012 Dec 20. Review.

11.

Effects of lifestyle modification in polycystic ovarian syndrome.

Moran LJ, Brinkworth G, Noakes M, Norman RJ.

Reprod Biomed Online. 2006 May;12(5):569-78. Review.

PMID:
16790100
12.

Role of changes in dietary habits in polycystic ovary syndrome.

Pasquali R, Gambineri A.

Reprod Biomed Online. 2004 Apr;8(4):431-9. Review.

PMID:
15149567
13.

Exercise therapy in polycystic ovary syndrome.

Hoeger KM.

Semin Reprod Med. 2008 Jan;26(1):93-100. doi: 10.1055/s-2007-992929. Review.

PMID:
18181087
14.

Exercise for the treatment and management of overweight women with polycystic ovary syndrome: a review of the literature.

Thomson RL, Buckley JD, Brinkworth GD.

Obes Rev. 2011 May;12(5):e202-10. doi: 10.1111/j.1467-789X.2010.00758.x. Review.

PMID:
20546140
15.

Metabolic syndrome and polycystic ovary syndrome: an intriguing overlapping.

Caserta D, Adducchio G, Picchia S, Ralli E, Matteucci E, Moscarini M.

Gynecol Endocrinol. 2014 Jun;30(6):397-402. doi: 10.3109/09513590.2014.887673. Epub 2014 Feb 19. Review.

PMID:
24552422
16.
17.

Obesity and the polycystic ovary syndrome.

Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R.

Int J Obes Relat Metab Disord. 2002 Jul;26(7):883-96. Review.

PMID:
12080440
18.

Insulin-sensitisers in the treatment of polycystic ovary syndrome.

Teede HJ, Meyer C, Norman RJ.

Expert Opin Pharmacother. 2005 Nov;6(14):2419-27. Review.

PMID:
16259573
19.

Polycystic ovary syndrome, obesity and reproductive implications.

Hirschberg AL.

Womens Health (Lond Engl). 2009 Sep;5(5):529-40; quiz 541-2. doi: 10.2217/whe.09.39. Review.

PMID:
19702452
20.

Polycystic ovary syndrome and metabolic comorbidities: therapeutic options.

De Leo V, Musacchio MC, Palermo V, Di Sabatino A, Morgante G, Petraglia F.

Drugs Today (Barc). 2009 Oct;45(10):763-75. doi: 1396674/dot.2009.45.10.1429463. Review.

PMID:
20069140
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk